{
    "organizations": [],
    "uuid": "2e2bfa4ba1843d3a82d90fa0f7e525604aedcf8a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-boston-scientific-says-co-prevails/brief-boston-scientific-says-co-prevails-in-uk-edwards-lifesciences-litigation-idUSFWN1RA0BH",
    "ord_in_thread": 0,
    "title": "BRIEF-Boston Scientific says co prevails in UK Edwards Lifesciences Litigation​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28, 2018 / 9:30 AM / in 21 minutes BRIEF-Boston Scientific says co prevails in UK Edwards Lifesciences Litigation​ Reuters Staff \nMarch 28 (Reuters) - Boston Scientific Corp: \n* BOSTON SCIENTIFIC CORP SAYS ‍BOSTON SCIENTIFIC PREVAILS IN U.K. EDWARDS LIFESCIENCES LITIGATION​ \n* TO APPEAL U.S. PATENT OFFICE’S RECENT FINDING THAT CERTAIN CLAIMS OF CO’S U.S. PATENT 8,992,608 ASSERTED AGAINST EDWARDS ARE INVALID​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-28T12:28:00.000+03:00",
    "crawled": "2018-03-28T12:40:10.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "scientific",
        "say",
        "co",
        "prevails",
        "uk",
        "edward",
        "lifesciences",
        "reuters",
        "staff",
        "march",
        "reuters",
        "boston",
        "scientific",
        "corp",
        "boston",
        "scientific",
        "corp",
        "say",
        "scientific",
        "prevails",
        "edward",
        "lifesciences",
        "appeal",
        "patent",
        "office",
        "recent",
        "finding",
        "certain",
        "claim",
        "co",
        "patent",
        "asserted",
        "edward",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}